SecBot SecBot
SECBOTREPLAY Home › Report › BCAX

BCAX · Bicara Therapeutics granted a stock option to purchase 115,000 shares…

Bicara Therapeutics Inc. · PRESS-RELEASE filed Mar 4, 2026 at 08:30 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 4, 2026 at 08:30 ET

Bicara Therapeutics granted a stock option to purchase 115,000 shares to a new employee as an inducement to employment, issued outside its shareholder-approved equity plans under the newly adopted 2026 Inducement Plan. The move is routine for new hires and does not reflect material financial or clinical developments.

  • Bicara Therapeutics issued a stock option to purchase 115,000 shares to a new employee on March 2, 2026.
  • Exercise price of $17.59 equals the Nasdaq closing price on the grant date.
  • Vesting: 25% on first anniversary, remainder in 12 equal quarterly installments.
  • Grant made under the 2026 Inducement Plan, approved by independent directors per Nasdaq Rule 5635(c)(4).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access